Others have already suggested this: “We propose that AD could be tackled not only using combination therapies including Aβ and tau, but also considering insulin and cholesterol metabolism, vascular function, synaptic plasticity, epigenetics, neurovascular junction and blood–brain barrier targets” [114]. The gene discussed is INS; the disease is Alzheimer disease.